Arcutis Biotherapeutics Gross Margin Growth & History (ARQT)

Arcutis Biotherapeutics's gross margin was 90.14% for fiscal 2025.

View full Arcutis Biotherapeutics company overview

Arcutis Biotherapeutics annual gross margin history

Arcutis Biotherapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3190.14%+1.62 pp
20242024-12-3188.51%+5.60 pp
20232023-12-3182.91%+3.37 pp
20222022-12-3179.54%

Arcutis Biotherapeutics gross margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Arcutis Biotherapeutics's gross margin increased from 79.54% to 90.14%, a change of +10.59 percentage points. The latest reported quarter, Q2 2026, shows 91.58%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Arcutis Biotherapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ARQT yet. Start the conversation.

Write the first post